Foundational Research
Advance could expand immune therapy as a cancer treatment
The development of antibody-lectin chimeras, which started in the lab of Stanford chemist Carolyn Bartozzi, shows promise in blocking the defenses put up by cancer cells and allowing the immune system to attack the diseased cells more effectively.
